Jason A. Leverone - Net Worth and Insider Trading

Jason A. Leverone Net Worth

The estimated net worth of Jason A. Leverone is at least $61,201 dollars as of 2026-09-11. Jason A. Leverone is the CFO of OnKure Therapeutics Inc and owns about 18,802 shares of OnKure Therapeutics Inc (OKUR) stock worth over $61,201. Details can be seen in Jason A. Leverone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason A. Leverone has not made any transactions after 2026-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jason A. Leverone

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Jason A. Leverone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason A. Leverone owns 2 companies in total, including Viridian Therapeutics Inc (VRDN) , and OnKure Therapeutics Inc (OKUR) .

Click here to see the complete history of Jason A. Leverone’s form 4 insider trades.

Insider Ownership Summary of Jason A. Leverone

Ticker Company Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2021-01-18 Chief Financial Officer
OKUR OnKure Therapeutics Inc 2026-06-22 Chief Financial Officer

Jason A. Leverone Latest Holdings Summary

Jason A. Leverone currently owns a total of 1 stock. Jason A. Leverone owns 18,802 shares of OnKure Therapeutics Inc (OKUR) as of June 22, 2026, with a value of $61,201.

Latest Holdings of Jason A. Leverone

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OKUR OnKure Therapeutics Inc 2026-06-22 18,802 3.26 61,201

Holding Weightings of Jason A. Leverone


Jason A. Leverone Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason A. Leverone has made a total of 6 transactions in OnKure Therapeutics Inc (OKUR) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in OnKure Therapeutics Inc is the sale of 303 shares on June 22, 2026, which brought Jason A. Leverone around $1,333.

Insider Trading History of Jason A. Leverone

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason A. Leverone Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Jason A. Leverone owns.
View OKUR Analysis

Jason A. Leverone Ownership Network

Ownership Network List of Jason A. Leverone

No Data

Ownership Network Relation of Jason A. Leverone

Insider Network Chart


Jason A. Leverone Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Jason A. Leverone is the Chief Financial Officer of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include Chief Legal Officer Jennifer Tousignant , director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc , and Chief Medical Officer Radhika Tripuraneni .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Jason A. Leverone made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,631,015 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net sale of 16,484 shares made by Jennifer Tousignant .

In summary, during the past 3 months, insiders sold 14,212 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 14,212 shares. During the past 18 months, 16,484 shares of Viridian Therapeutics Inc (VRDN) were sold and 1,631,015 shares were bought by its insiders, resulting in a net purchase of 1,614,531 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Jason A. Leverone Mailing Address

Above is the net worth, insider trading, and ownership report for Jason A. Leverone. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jason A. Leverone's mailing address is: Boulder Co 80301.